Disparities in Access and Mortality of Patients With ST-Segment-Elevation Myocardial Infarction Using the Brazilian

Jussiely Cunha Oliveira1,2, Marcos Antonio Almeida-Santos3,4, Jeferson Cunha-Oliveira1,5,6

  • 1Postgraduate Program in Health Sciences Federal University of Sergipe Aracaju Sergipe Brazil.

Insights

Patients in Brazil's public health system (SUS) experienced longer delays for ST-segment-elevation myocardial infarction treatment and had higher mortality rates compared to private healthcare patients. Primary percutaneous coronary intervention (PCI) use was also lower in the SUS group.

Area of Science:

  • Cardiology
  • Public Health
  • Health Equity

Background:

  • ST-segment-elevation myocardial infarction (STEMI) management disparities between public and private healthcare systems in Brazil are understudied.
  • Understanding treatment access and outcomes for STEMI patients is crucial for public health policy.

Purpose of the Study:

  • To compare myocardial reperfusion rates and 30-day mortality for STEMI patients between Brazil's public health system (SUS) and the private healthcare system.
  • To identify potential disparities in STEMI care delivery and outcomes.

Main Methods:

  • Analysis of 707 STEMI patients from the VICTIM register database.
  • Comparison of treatment timelines, primary percutaneous coronary intervention (PCI) rates, and 30-day mortality between SUS and private healthcare users.
  • Statistical adjustment for potential confounding factors in mortality analysis.

Main Results:

  • SUS patients had significantly longer symptom onset to hospital arrival times (25.4 vs. 9.0 hours).
  • Primary PCI rates were substantially lower in the SUS group (45% vs. 78%).
  • 30-day mortality was higher for SUS patients (11.9% vs. 5.9%), with adjusted odds ratio of 2.96.

Conclusions:

  • Significant delays in reaching PCI-capable hospitals exist for SUS patients.
  • Primary PCI is underutilized in both systems, particularly within the SUS.
  • SUS patients face a higher risk of 30-day mortality following STEMI.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.2K
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.9K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.7K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
190
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
690